Brief: Seikagaku initiates phase II study of SI-613 for treatment of knee osteoarthritis in U.S.
16/06/2017 05:14
June 16(Reuters) - Seikagaku Corp 4548.T
* Says it announces the start of phase II study of SI-613 in
patients with osteoarthritis of the knee, in the U.S.
Source text in Japanese:https://goo.gl/F8pM1P
Further company coverage: 4548.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))